Dare Bioscience (DARE) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts DARE Hot Sheet
Join SI Premium – FREE
Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.09), in-line with the analyst estimate of ($0.09).
For earnings history and earnings-related data on Dare Bioscience (DARE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
